• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Pediatrics

Type of e-cigarette impacts risk of subsequent cigarette smoking

byAlex Gipsman, MDandLeah Carr, MD
April 6, 2020
in Pediatrics, Public Health, Pulmonology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Among those surveyed, individuals who reported using modifiable e-cigarettes, known as “mods,” smoked more than 6 times as many cigarettes at follow up than those who endorsed the use of non-modifiable vaping “pens.”

2. Recent e-cigarette users smoked more than 5 times as many cigarettes at follow-up as those who had never used e-cigarettes.

Evidence Rating Level: 2 (Good)

Study Rundown: Recent data have shown that e-cigarette use or “vaping” in high school students has been increasing at an alarming rate, and that those who vape are more likely to subsequently smoke combustible cigarettes. Despite this prior work, there is little known about whether the specific e-cigarette delivery device impacts subsequent cigarette usage. This study attempted to elucidate risk factors for transitioning from vaping to cigarette smoking, with a focus on e-cigarette characteristics and delivery systems. Participants were surveyed regarding their historical use of e-cigarettes and combustible cigarettes and underwent follow-up 1 year later. Those who reported vaping at baseline were more likely to smoke cigarettes at follow-up. Compared to the e-cigarette “pen,” use of a “mod” device (which enables a user to modify temperature, amount of nicotine delivered, and size of vape cloud) was associated with reported increased cigarettes smoked in the past 30 days at the 1 year follow-up. Nicotine levels in e-liquid used during vaping were not associated with subsequent frequency of cigarette smoking. Though limited by a lack of inclusion of information regarding popular pod-based e-cigarettes due to the timing of the surveys and potential lack of generalizability to younger adolescents (all participants were > 18 years of age), this study provides valuable data regarding possible targets for e-cigarette regulation. By aiming to decrease the number of adolescents who vape, there is the potential to reduce adolescents’ transition to combustible cigarette smoking.

Click to read the study, published today in Pediatrics

Relevant Reading: Notes from the field: use of electronic cigarettes and any tobacco product among middle and high school students – United States, 2011-2018

RELATED REPORTS

Baseline cannabis use may not be associated with abstinence from vaping

2 Minute Medicine Rewind December 15, 2025

In-Depth [prospective cohort]: This study used data collected from the Southern California Children’s Health Study from 2015 – 2017.  A total of 1312 participants were included in the analysis (52% female, 87% Hispanic or non-Hispanic white). Participants initially reported the age at which they first used e-cigarettes and how often they vaped in the past 30 days. Data regarding sex, ethnicity, and parental education were also collected. Follow-up data regarding number of cigarettes smoked in the last 30 days was obtained 1 year later. Nearly 37% (n = 484) of participants reported having ever vaped at baseline, with 10.5% (n = 138) having vaped in the past 30 days. At 1-year follow-up, the average number of cigarettes smoked in the past 30 days was higher in males, previous e-cigarette users, and those whose parents had some college or a college degree or higher. There were no differences in cigarettes smoked between race/ethnicity. Participants who reported using a modifiable device at baseline smoked an average of 5.11 times as many cigarettes in the past 30 days at 1-year follow-up compared to those who used pen-like devices at baseline (95% CI 1.74-15.0). “Mod” users also smoked 8.38 times as many cigarettes in the past 30 days at follow-up compared to those who had never vaped at baseline (95% CI 4.87-14.4), whereas pen-like device users smoked 2.83 times as many cigarettes as those who had never vaped at baseline (95% CI 1.26-6.35).

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cigarettee-cigarettetobacco abusevaping
Previous Post

Policy statement outlines recommendations on management of infants born to mothers with COVID-19

Next Post

2 Minute Medicine Rewind April 6, 2020

RelatedReports

Cannabis and alcohol use collage: an engraved cannabis leaf, an empty tumbler glass and a car steering wheel by a road ribbon
Chronic Disease

Baseline cannabis use may not be associated with abstinence from vaping

January 13, 2026
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Weekly Rewinds

2 Minute Medicine Rewind December 15, 2025

December 15, 2025
Vaping to quit smoking collage: a woman in a work jacket above a row of ever-shorter unlit cigarettes ending in a vape
Public Health

Vaporized nicotine products may be effective for smoking cessation among people with social disadvantage

July 14, 2025
#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder
StudyGraphics

#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder

April 16, 2025
Next Post
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial

2 Minute Medicine Rewind April 6, 2020

Insclisiran significantly decreases LDL cholesterol in heterozygous familial hypercholesterolemia patients

Initial data on the viability of SARS-CoV-2 in aerosol and on surfaces

Conversion of pharyngeal specimens from SARS-nCoV-2-positive to negative may not correlate with end of viral shedding

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.